Home The Wall Street Journal: NovoCure falls below reduced IPO price in market debut
 

Keywords :   


The Wall Street Journal: NovoCure falls below reduced IPO price in market debut

2015-10-03 22:12:05| Biotech - Topix.net

Shares in oncology company NovoCure Ltd. fell sharply in their trading debut Friday, the latest example of investors' waning appetite for biotechnology shares and for initial public offerings. shares opened at $20.16, below their initial public offering price of $22.

Tags: price street market journal

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
08.11Nissan to lay off thousands of workers as sales drop
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 18
08.11Hurricane Rafael Forecast Discussion Number 18
08.11Hurricane Rafael Forecast Advisory Number 18
08.11Hurricane Rafael Public Advisory Number 18
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Up close with the 300 tonne driverless trucks
More »